Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

SC-514 - CAS# 354812-17-2 Catalog No.:M6663-2 PubMed PMID: 24660890

SKU: 82460566095

4.7
DKK20.00 DKK58.00

Pay in 4 interest-free payments of $5.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

SC-514 - CAS# 354812-17-2 Catalog No.:M6663-2 PubMed PMID: 24660890SC 514, CAS No. 354812 17 2, is a selective and reversible inhibitor of IB kinase 2 (IKK2) that may target osteoclastogenesis. SC 514 dose dependently inhibits RANKL induced osteoclastogenesis and induced apoptosis and caspase 3 activation in RAW264. 7 cells. Targeting IKK by SC 514 may be a potential treatment for osteoclast related disorders such as osteoporosis and cancer induced bone loss. Product information CAS Number: 354812 17 2 Molecular

Store: selfdriverentaluganda.com · Domain: selfdriverentaluganda.com

Description

PubMed PMID: 24660890

Lower concentration (0

C[N+]1=C2C=CC(=CC2=CC=C1/C=C/C1C=C(C)N(C2C=CC=CC=2)C=1C)N(C)C

Ferrer-Torres D

and in vivo active LRRK2 kinase inhibitor

SC-514 - CAS# 354812-17-2 Catalog No.:M6663-2 PubMed PMID: 24660890SC 514, CAS No. 354812 17 2, is a selective and reversible inhibitor of IB kinase 2 (IKK2) that may target osteoclastogenesis. SC 514 dose dependently inhibits RANKL induced osteoclastogenesis and induced apoptosis and caspase 3 activation in RAW264. 7 cells. Targeting IKK by SC 514 may be a potential treatment for osteoclast related disorders such as osteoporosis and cancer induced bone loss. Product information CAS Number: 354812 17 2 Molecular

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products